INR:9994. wingo win login AstraZeneca's dapagliflozin marketing application receives FDA priority review Genetic link between diabetes and fracture risk revealed ...

Under the new regulations on expanding volume-based procurement, which local pharmaceutical company can become the "king" of expansion? Worrying! WHO points to a surge in HIV drug resistance in Asia, ...

INR:0299. ryan wingo interview Rotavirus vaccine shows promise in overcoming resistance to immune checkpoint blockade therapy Bituowei is approved by China's ...

INR:1990. roadkill tv series An article to understand HIV drug resistance and detection Current Comment: Beijing’s large-scale clinical review involves the d ...

In 2025, public health concerns focus on the threats of bird flu, malaria, HIV, and tuberculosis. H5N1 influenza poses a ...

Currently, lenacapavir is approved in the US and other countries for the treatment of adults with drug-resistant HIV. But in ...

Science magazine has chosen twice-yearly lenacapavir PrEP as its 2024 Breakthrough of the Year, recognizing it as a ...

Merck's experimental two-drug combination met the main goal of significantly suppressing replication of the HIV-1 virus in ...

Corticosteroids had no effect on mortality rates or serious adverse events in patients with HIV and tuberculosis, showed a recent meta-analysis.

Several giant US and international groups focused on fighting HIV and AIDS on Tuesday unveiled a plan to swiftly provide ...

A new long-acting preventive HIV drug could reach the world’s poorest countries by the end of 2025 or early 2026, a global ...

Lenacapavir, a treatment administered subcutaneously every six months, is capable of preventing infection with very high ...